8RQA
Crystal structure of CRBN-midi in complex with Lenalidomide
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | DIAMOND BEAMLINE I24 |
Synchrotron site | Diamond |
Beamline | I24 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2023-06-30 |
Detector | DECTRIS EIGER2 S 9M |
Wavelength(s) | 0.6199 |
Spacegroup name | C 2 2 21 |
Unit cell lengths | 51.989, 95.717, 148.252 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 45.540 - 2.500 |
R-factor | 0.3019 |
Rwork | 0.300 |
R-free | 0.34200 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.015 |
RMSD bond angle | 1.688 |
Data reduction software | autoPROC |
Data scaling software | autoPROC |
Phasing software | PHASER |
Refinement software | PHENIX (1.20.1_4487) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 45.540 | 2.540 |
High resolution limit [Å] | 2.500 | 2.500 |
Rmerge | 0.200 | 1.782 |
Number of reflections | 13030 | 1181 |
<I/σ(I)> | 5.046 | 1.17 |
Completeness [%] | 99.7 | 96.4 |
Redundancy | 4.8 | |
CC(1/2) | 0.990 | 0.420 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 8 | 293 | 0.1 M Tris pH 8, 20 % w/v PEG 4000, 1.2 % myo-inositol |